Series B - Alebund Pharmaceuticals - Sep 13, 2021 Funding Round Profile - Cointime

Bitcoin $95,500.49 -0.65%
Ethereum $3,315.38 -0.38%
BNB $661.95 +1.02%
Optimism $1.79 +3.18%
Arbitrum $0.76 +2.62%
Solana $183.78 +1.82%
Polygon $0.48 +2.17%
Cosmos $6.48 +0.30%
Avalanche $36.85 -0.70%

Bitcoin $95,500.49 -0.65%
Ethereum $3,315.38 -0.38%
BNB $661.95 +1.02%
Optimism $1.79 +3.18%
Arbitrum $0.76 +2.62%
Solana $183.78 +1.82%
Polygon $0.48 +2.17%
Cosmos $6.48 +0.30%
Avalanche $36.85 -0.70%

Alebund Pharmaceuticals

company

Funding Round

Series B

Money Raised

$ 54.50M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Lilly Asia Ventures	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
May 9, 2021	Series B	$ 60M	Lilly Asia Ventures	Detail
Jan 1, 2020	Series A	0	Lilly Asia Ventures	Detail